| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Canadian Journal of Anesthesia, Vol 45, 670-682, Copyright © 1998 by Canadian Anesthesiologists' Society
ARTICLES |
A Hawaleshka and E Jacobsohn
Department of Anaesthesia, University of Manitoba, Health Sciences Centre, Winnipeg, Canada.
PURPOSE: Brief ischaemic episodes, followed by periods of reperfusion, increase the resistance to further ischaemic damage. This response is called "ischaemic preconditioning." By reviewing the molecular basis and fundamental principals of ischaemic preconditioning, this paper will enable the anaesthetic and critical care practitioner to understand this developing therapeutic modality. SOURCE: Articles were obtained from a Medline review (1960-1997; search terms: ischaemia, reperfusion injury, preconditioning, ischaemic preconditioning, cardiac protection). Other sources include review articles, textbooks, hand-searches (Index Medicus), and personal files. PRINCIPLE FINDING: Ischaemic preconditioning is a powerful protective mechanism against ischaemic injury that has been shown to occur in a variety of organ systems, including the heart, brain, spinal cord, retina, liver, lung and skeletal muscle. Ischaemic preconditioning has both immediate and delayed protective effects, the importance of which varies between species and organ systems. While the exact mechanisms of both protective components are yet to be clearly defined, ischaemic preconditioning is a multifactorial process requiring the interaction of numerous signals, second messengers and effector mechanisms. Stimuli other than ischaemia, such as hypoxic perfusion, tachycardia and pharmacological agents, including isoflurane, have preconditioning-like effects. Currently ischaemic preconditioning is used during minimally invasive cardiac surgery without cardiopulmonary bypass to protect the myocardium against ischaemic injury during the anastomosis. CONCLUSION: Ischaemic preconditioning is a powerful protective mechanism against ischaemic injury in many organ systems. Future clinical applications will depend on the clarification of the underlying biochemical mechanisms, the development of pharmacological methods to induce preconditioning, and controlled trials in humans showing improved outcomes.
This article has been cited by other articles:
![]() |
M. P Mattson Hormesis and disease resistance: activation of cellular stress response pathways Human and Experimental Toxicology, February 1, 2008; 27(2): 155 - 162. [Abstract] [PDF] |
||||
![]() |
T. Yue, B. Roth Z'graggen, S. Blumenthal, S. B. Neff, L. Reyes, C. Booy, M. Steurer, D. R. Spahn, T. A. Neff, E. R. Schmid, et al. Postconditioning with a volatile anaesthetic in alveolar epithelial cells in vitro Eur. Respir. J., January 1, 2008; 31(1): 118 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, H. Qian, P. Zhao, S.-S. Hong, and Y. Xia Rapid Hypoxia Preconditioning Protects Cortical Neurons From Glutamate Toxicity Through {delta}-Opioid Receptor Stroke, April 1, 2006; 37(4): 1094 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. B. Contreras, L. F. P. Moreira, G. Ballester, B. A. de Monaco, C. L. P. Lancellotti, A. R. Dias, and S. A. Oliveira Immediate ischemic preconditioning based on somatosensory evoked potentials seems to prevent spinal cord injury following descending thoracic aorta cross-clamping Eur. J. Cardiothorac. Surg., August 1, 2005; 28(2): 274 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Dobkowski Myocardial Protection During Minimally Invasive Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2002; 6(4): 319 - 324. [Abstract] [PDF] |
||||
![]() |
L. Yao, R. Kato, and P. Foex Isoflurane-induced protection against myocardial stunning is independent of adenosine 1 (A1) receptor in isolated rat heart Br. J. Anaesth., August 1, 2001; 87(2): 258 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Johnston Preconditioning the Brain and Heart: Implications for Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 70 - 79. [Abstract] [PDF] |
||||
![]() |
S. Ganapathy, W. Dobkowski, J. M. Murkin, and W. D. Boyd Anesthesia and Regional Anesthetic Techniques for Minimally Invasive Direct Coronary Artery Bypass Surgery Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 92 - 102. [Abstract] [PDF] |
||||
![]() |
L Cai Research of the adaptive response induced by low-dose radiation: where have we been and where should we go? Human and Experimental Toxicology, July 1, 1999; 18(7): 419 - 425. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |